The authors review the role of different molecular determinants of prostate cancer progression to lethal disease including the phenotypic dynamic of cell plasticity, EMT-MET interconversion, and signaling-pathways driving prostate cancer cells to advance and metastasize.
[Expert Opinion On Therapeutic Targets]